|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Campo E: Whole genome profiling and other
high throughput technologies in lymphoid neoplasms - current
contributions and future hopes. Mod Pathol. 26:S97–S110. 2013.
View Article : Google Scholar
|
|
3
|
Ajiro M, Katagiri T, Ueda K, et al:
Involvement of RQCD1 over-expression, a novel cancer-testis
antigen, in the Akt pathway in breast cancer cells. Int J Oncol.
35:673–681. 2009.PubMed/NCBI
|
|
4
|
Kim JW, Fukukawa C, Ueda K, Nishidate T,
Katagiri T and Nakamura Y: Involvement of C12orf32 overexpression
in breast carcinogenesis. Int J Oncol. 37:861–867. 2010.PubMed/NCBI
|
|
5
|
Shimo A, Nishidate T, Ohta T, Fukuda M,
Nakamura Y and Katagiri T: Elevated expression of protein regulator
of cytokinesis 1, involved in the growth of breast cancer cells.
Cancer Sci. 98:174–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimo A, Tanikawa C, Nishidate T, et al:
Involvement of kinesin family member 2C/mitotic
centromere-associated kinesin overexpression in mammary
carcinogenesis. Cancer Sci. 99:62–70. 2008.
|
|
7
|
Kim JW, Akiyama M, Park JH, et al:
Activation of an estrogen/estrogen receptor signaling by BIG3
through its inhibitory effect on nuclear transport of PHB2/REA in
breast cancer. Cancer Sci. 100:1468–1478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshimaru T, Komatsu M, Matsuo T, et al:
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in
breast cancer cells. Nat Commun. 4:24432013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Agrawal A, Murphy RF and Agrawal DK: DNA
methylation in breast and colorectal cancers. Mod Pathol.
20:711–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Z, Xiao Q, Zhao L, et al: DNA
methyltransferase 1/3a over-expression in sporadic breast cancer is
associated with reduced expression of estrogen
receptor-alpha/breast cancer susceptibility gene 1 and poor
prognosis. Mol Carcinog. Jan 25–2014.(Epub ahead of print).
View Article : Google Scholar
|
|
11
|
Radpour R, Kohler C, Haghighi MM, Fan AX,
Holzgreve W and Zhong XY: Methylation profiles of 22 candidate
genes in breast cancer using high-throughput MALDI-TOF mass array.
Oncogene. 28:2969–2978. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Niwa Y, Oyama T and Nakajima T: BRCA1
expression status in relation to DNA methylation of the BRCA1
promoter region in sporadic breast cancers. Jpn J Cancer Res.
91:519–526. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barekati Z, Radpour R, Lu Q, et al:
Methylation signature of lymph node metastases in breast cancer
patients. BMC Cancer. 12:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van De Voorde L, Speeckaert R, Van Gestel
D, et al: DNA methylation-based biomarkers in serum of patients
with breast cancer. Mutat Res. 751:304–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Medina-Franco JL and Caulfield T: Advances
in the computational development of DNA methyltransferase
inhibitors. Drug Discov Today. 16:418–425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schrump DS, Fischette MR, Nguyen DM, et
al: Phase I study of decitabine-mediated gene expression in
patients with cancers involving the lungs, esophagus, or pleura.
Clin Cancer Res. 12:5777–5785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Issa JP, Kantarjian HM and Kirkpatrick P:
Azacitidine. Nature Rev Drug Discov. 4:275–276. 2005. View Article : Google Scholar
|
|
18
|
Lin J, Deng Z, Tanikawa C, et al:
Downregulation of the tumor suppressor HSPB7, involved in the p53
pathway, in renal cell carcinoma by hypermethylation. Int J Oncol.
44:1490–1498. 2014.PubMed/NCBI
|
|
19
|
Nishidate T, Katagiri T, Lin ML, et al:
Genome-wide gene-expression profiles of breast-cancer cells
purified with laser microbeam microdissection: identification of
genes associated with progression and metastasis. Int J Oncol.
25:797–819. 2004.PubMed/NCBI
|
|
20
|
Tanikawa C, Furukawa Y, Yoshida N, Arakawa
H, Nakamura Y and Matsuda K: XEDAR as a putative colorectal tumor
suppressor that mediates p53-regulated anoikis pathway. Oncogene.
28:3081–3092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clark HF, Gurney AL, Abaya E, et al: The
secreted protein discovery initiative (SPDI), a large-scale effort
to identify novel human secreted and transmembrane proteins: a
bioinformatics assessment. Genome Res. 13:2265–2270. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakayama Y, Nara N, Kawakita Y, et al:
Cloning of cDNA encoding a regeneration-associated muscle protease
whose expression is attenuated in cell lines derived from Duchenne
muscular dystrophy patients. Am J Pathol. 164:1773–1782. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao Y, Niu Y, Wang X, et al: Chromosome
aberrations associated with centrosome defects: a study of
comparative genomic hybridization in breast cancer. Hum Pathol.
42:1693–1701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hawthorn L, Luce J, Stein L and Rothschild
J: Integration of transcript expression, copy number and LOH
analysis of infiltrating ductal carcinoma of the breast. BMC
Cancer. 10:4602010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Bove B, Wu Y, et al:
Microsatellite instability during the immortalization and
transformation of human breast epithelial cells in vitro. Mol
Carcinog. 24:118–127. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng CJ, Lin YC, Tsai MT, et al: SCUBE2
suppresses breast tumor cell proliferation and confers a favorable
prognosis in invasive breast cancer. Cancer Res. 69:3634–3641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin YC, Lee YC, Li LH, Cheng CJ and Yang
RB: Tumor suppressor SCUBE2 inhibits breast-cancer cell migration
and invasion through the reversal of epithelial-mesenchymal
transition. J Cell Sci. 127:85–100. 2014. View Article : Google Scholar
|
|
29
|
Lin YC, Chen CC, Cheng CJ and Yang RB:
Domain and functional analysis of a novel breast tumor suppressor
protein, SCUBE2. J Biol Chem. 286:27039–27047. 2011. View Article : Google Scholar : PubMed/NCBI
|
